FTXHvsBBHETF Comparison
VS
First Trust Nasdaq Pharmaceuticals ETF (FTXH) and VanEck Biotech ETF (BBH) belong to the same industry segment: US Health Care. Both ETFs have the same top 1 sector exposures: Healthcare. FTXH is more expensive with a Total Expense Ratio (TER) of 0.6%, versus 0.35% for BBH. FTXH is up 23.32% year-to-date (YTD) with +$978M in YTD flows. BBH performs worse with 21.21% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of FTXH and BBH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.
Find out how industry players manage ETF portfolios. Discover our library of Model portfolios
FTXH vs BBH performance and flow charts
Performance
Cumulative Flows
Historic performance and flows
Data as of 09/10/2026
| 1M | 3M | YTD | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|---|---|
| Perf. | FTXH BBH | +0.75%+4.37% | +14.81%+22.01% | +23.32%+21.21% | +46.70%+36.00% | +58.20%+44.15% | +66.91%+10.65% |
| Flows | FTXH BBH | +$41M+$15M | +$968M+$15M | +$978M+$7M | +$981M-$14M | +$973M-$149M | +$977M-$135M |
Volatility and drawdown
| 3M | 1Y | 3Y | 5Y | ||
|---|---|---|---|---|---|
| Volatility | FTXH BBH | +20.07%+27.24% | +17.74%+21.86% | +16.99%+20.22% | +16.34%+21.81% |
| Max drawdown | FTXH BBH | -5.34%-6.32% | -7.50%-10.54% | -19.32%-22.78% | -19.32%-39.16% |
| Max drawdown duration | FTXH BBH | 16d23d | 99d150d | 393d440d | 393d1778d |
Trading data
FTXH | BBH | |
Last sale 9/11/2026 at 1:30 PM | $40.47 | $229.39 |
| Previous close 09/10/2026 | $40.52 | $228.64 |
| Consolidated volume 09/10/2026 | ||
| Average volume 30 days | ||
| Average discount or premium 30 days | ||
| Average Bid/Ask spread 30 days |
Replication quality
Data as of August 31, 2026
1-year trailing difference
Create an account to view replication metrics
Join for free
FTXH | BBH | |
|---|---|---|
| Tracking error | ||
| Tracking difference | ||
| 1 year cumulative return difference | ||
| Best | ||
| Worst | ||
| Daily return difference | ||
| Average | ||
| Worst | ||
Advertisement
Main metrics
Last update 9/11/2026 at 1:30 PM
Live
Closed
FTXH | BBH | |
|---|---|---|
| Last price | $40.47 | $229.39 |
| 1D performance | -0.13% | +0.33% |
| AuM | $1.04 B | $460.10 M |
| E/R | 0.6% | 0.35% |
Characteristics
FTXH | BBH | |
|---|---|---|
| Management strategy | Passive | Passive |
| Provider | First Trust | VanEck |
| Benchmark | NASDAQ US Smart Pharmaceuticals Index | MVIS US Listed Biotech 25 Index |
| N° of holdings | 49 | 24 |
| Asset class | Equities | Equities |
| Trailing 12m distribution yield | Join | Join |
| Inception date | September 20, 2016 | December 20, 2011 |
| ESG | No | No |
Advertisement
Exposure
Countries
FTXH
USA
95.79%
Other
4.21%
BBH
USA
87.55%
Other
12.45%
Sectors
FTXH
Healthcare
99.86%
Other
0.14%
BBH
Healthcare
100%
Advertisement
Diversification
FTXH
Total weight of top 15 holdings out of 15
66.98%
BBH
Total weight of top 15 holdings out of 15
85.32%
Top 15 holdings
Data as of July 31, 2026
FTXH
Merck & Co., Inc.
7.58%
Eli Lilly & Co.
7.43%
AbbVie, Inc.
7.11%
Johnson & Johnson
6.78%
Bristol Myers Squibb Co.
6.61%
Amgen, Inc.
3.53%
Biogen, Inc.
3.52%
Vertex Pharmaceuticals, Inc.
3.43%
Viatris, Inc.
3.40%
Regeneron Pharmaceuticals, Inc.
3.34%
Pfizer Inc.
3.17%
Cardinal Health, Inc.
3.14%
Gilead Sciences, Inc.
3.03%
Incyte Corp.
2.48%
United Therapeutics Corp.
2.43%
BBH
Amgen, Inc.
15.97%
Gilead Sciences, Inc.
12.99%
Vertex Pharmaceuticals, Inc.
8.62%
Regeneron Pharmaceuticals, Inc.
7.18%
Revolution Medicines, Inc.
5.29%
IQVIA Holdings, Inc.
5.18%
Natera, Inc.
4.77%
argenx SE
4.58%
Illumina, Inc.
3.62%
Biogen, Inc.
3.41%
BeOne Medicines Ltd.
3.10%
Moderna, Inc.
2.72%
United Therapeutics Corp.
2.68%
Incyte Corp.
2.65%
Alnylam Pharmaceuticals, Inc.
2.56%
Frequently asked questions about FTXH and BBH
How have the FTXH and BBH ETFs performed in 2026?
As of September 10, 2026, FTXH is up 23.32% year-to-date (YTD), while BBH has returned 21.21%. That puts FTXH better performer ahead so far this year.
Which ETF is attracting more investor money: FTXH or BBH?
Year-to-date, the FTXH ETF saw +$978M in flows, compared to +$7M for BBH.
Which ETF is more volatile: FTXH or BBH?
Over the past year, FTXH had a volatility of 17.74%, while BBH experienced 21.86%.
Which ETF is bigger: FTXH or BBH?
As of September 10, 2026, FTXH holds $1.04 B in assets under management (AUM), while BBH manages $460.10 M.
What sectors do the FTXH and BBH ETFs invest in?
FTXH leans toward sectors like Healthcare. Meanwhile, BBH focuses on Healthcare.
What are the top holdings of the FTXH ETF and BBH ETF?
FTXH top holdings include Merck & Co., Inc., Eli Lilly & Co. and AbbVie, Inc.. BBH holds in its top three: Amgen, Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals, Inc..
Which ETF is more diversified: FTXH or BBH?
FTXH holds 49 securities with 66.98% of its assets in the top 15. BBH has 24 securities and a top 15 weight of 85.32%.
Advertisement
Advertisement
